- Collection:
- Georgia Government Publications
- Serial:
- HIV surveillance summary, Georgia ...
- Title:
- HIV surveillance summary, Georgia, 2020
- Contributor to Resource:
- Georgia. Department of Public Health. HIV/AIDS Epidemiology Section. issuing body.
- Publisher:
- [Atlanta, Georgia] : Georgia Department of Public Health, Division of Health Protection, Epidemiology Program, HIV/AIDS Epidemiology Section, [2011]-
- Date of Original:
- 2020
- Subject:
- HIV infections--Georgia--Periodicals.
HIV-positive persons--Georgia--Periodicals.
HIV infections--fast
HIV-positive persons--fast
Georgia--fast
Georgia Government Documents--Serial - Location:
- United States, Georgia, 32.75042, -83.50018
- Medium:
- state government records
- Type:
- Text
- Format:
- application/pdf
- Description:
- Began with: 2011.
2011 (harvested from dph.georgia.gov); title from PDF title page (Georgia Government Publications database, viewed August 16, 2017).
2015 (Georgia Government Publications database, viewed August 16, 2017). - External Identifiers:
- Metadata URL:
- https://dlg.galileo.usg.edu/id:dlg_ggpd_1001288314-2020
- Digital Object URL:
- https://dlg.galileo.usg.edu/do:dlg_ggpd_1001288314-2020
- Language:
- eng
- Holding Institution:
- University of Georgia. Map and Government Information Library
- Rights:
-
HIV Surveillance Summary
Georgia, 2020
HIV/AIDS Epidemiology Section Epidemiology Program Division of Health Protection Georgia Department of Public Health
2020 Georgia HIV Surveillance Summary
Page 1
The HIV Surveillance Summary, Georgia 2020 is published by the Georgia Department of Public Health (DPH), HIV/AIDS Epidemiology Section (HAES), 2 Peachtree Street NW, Atlanta, Georgia 30303. Data are presented from known diagnoses and laboratory reports entered into the Georgia Enhanced HIV/AIDS Reporting System (eHARS). All data are provisional.
The HIV Surveillance Summary, Georgia 2020 is not copyrighted and may be used and reproduced without permission. Citation of the source is, however, appreciated.
SUGGESTED CITATION: Georgia Department of Public Health, HIV/AIDS Epidemiology Section HIV Surveillance Summary, Georgia 2020, https://dph.georgia.gov/data-fact-sheet-summaries, Published April 2022, [Accessed: date]
ACKNOWLEDGEMENTS: Publication of this report was made possible with the contributions of the Georgia DPH HAES Core HIV Surveillance staff, HIV Case Report Forms submitted by Georgia healthcare facility staff, HIV infection related laboratory test results transmitted by laboratory facilities in Georgia, data matches with other DPH programs, and the ongoing efforts of multiple individuals from public and private sector organizations dedicated to improving surveillance, prevention, testing, and care of persons living with HIV infection.
Georgia HIV Core Surveillance Team contributors: Jose Adame, Lauren Barrineau-Vejjajiva, Thelma Fannin, Latosha Johnson, Rodriques Lambert, Daniel Mauck, Mildred McGainey, Contessa Meadows, Latoya Moss, Kim Norris, Rama Namballa, Doris Pearson, A. Eugene Pennisi, Sylve Rawls, Akilah Spratling, and Gerriana Willams.
This report was prepared by the following staff from the Georgia Department of Public Health: Nellie Garlow, MPH, Pascale Wortley, MD, MPH; Cherie Drenzek, DVM, MS.
2020 Georgia HIV Surveillance Summary
Page 2
Table of Contents
INTRODUCTION ....................................................................................................................................................................... 5
TECHNICAL NOTES .................................................................................................................................................................. 6
Definitions ........................................................................................................................................................................... 6
References .......................................................................................................................................................................... 8
TABLES................................................................................................................................................................................... 10
HIV Diagnoses and persons living with HIV, Georgia, 2020 .............................................................................................. 11
Table 1. HIV diagnoses, late diagnoses, and stage 3 (AIDS) diagnoses, Georgia, 2020 ................................................ 11
Table 2. HIV diagnoses, late diagnoses, and stage 3 (AIDS) diagnoses among males, Georgia, 2020.......................... 12
Table 3. HIV diagnoses, late diagnoses, and stage 3 (AIDS) diagnoses among females, Georgia, 2020 ...................... 13
Table 4. HIV diagnoses, late diagnoses, and stage 3 (AIDS) diagnoses among transgender persons, Georgia, 2020.. 14
Table 5. Persons Living with HIV (PLWH), and PLWH ever Stage 3 (AIDS), Georgia, as of 12/31/2020 ....................... 15
Table 6. Persons living with HIV (PLWH), and PLWH ever stage 3 (AIDS), males, Georgia, as of 12/31/2020 ............. 16
Table 7. Persons Living with HIV (PLWH), and PLWH ever Stage 3 (AIDS), females, Georgia, as of 12/31/2020......... 17
Table 8. Persons Living with HIV (PLWH), and PLWH ever Stage 3 (AIDS), transgender persons, Georgia, as of 12/31/2020 ................................................................................................................................................................... 18
HIV Diagnoses and Persons Living with HIV by Public Health District .............................................................................. 19
Table 9. HIV Diagnoses and Persons Living with HIV, District 1-1 (Rome), Georgia, 2020 ........................................... 19
Table 10. HIV Diagnoses and Persons Living with HIV, District 1-2 (Dalton), Georgia, 2020........................................ 20
Table 11. HIV Diagnoses and Persons Living with HIV, District 2 (Gainesville), Georgia, 2020 .................................... 21
Table 12 HIV Diagnoses and Persons Living with HIV, District 3-1 (Cobb-Douglas), Georgia, 2020 ............................. 22
Table 13. HIV Diagnoses and Persons Living with HIV, District 3-2 (Fulton), Georgia, 2020 ........................................ 23
Table 14. HIV Diagnoses and Persons Living with HIV, District 3-3 (Clayton), Georgia, 2020 ...................................... 24
Table 15. HIV Diagnoses and Persons Living with HIV, District 3-4 (East Metro), Georgia, 2020................................. 25
Table 16. HIV Diagnoses and Persons Living with HIV, District 3-5 (DeKalb), Georgia, 2020 ..................................... 266
Table 17. HIV Diagnoses and Persons Living with HIV, District 4 (LaGrange), Georgia, 2020....................................... 27
Table 18. HIV Diagnoses and Persons Living with HIV, District 5-1 (Dublin), Georgia, 2020 ........................................ 28
Table 19. HIV Diagnoses and Persons Living with HIV, District 5-2 (Macon), Georgia, 2020 ....................................... 29
Table 20. HIV Diagnoses and Persons Living with HIV, District 6 (Augusta), Georgia, 2020......................................... 30
Table 21. HIV Diagnoses and Persons Living with HIV, District 7 Columbus), Georgia, 2020 ....................................... 31
Table 22. HIV Diagnoses and Persons Living with HIV, District 8-1 (Valdosta), Georgia, 2020..................................... 32
Table 23. HIV Diagnoses and Persons Living with HIV, District 8-2 (Albany), Georgia, 2020........................................ 33
Table 24. HIV Diagnoses and Persons Living with HIV, District 9-1 (Savannah), Georgia, 2020 ................................... 34
Table 25. HIV Diagnoses and Persons Living with HIV, District 9-2 (Waycross), Georgia, 2020 ................................... 35
2020 Georgia HIV Surveillance Summary
Page 3
Table 26. HIV Diagnoses and Persons Living with HIV, District 10 (Athens), Georgia, 2020 ........................................ 36 HIV Diagnoses and Persons Living with HIV, Atlanta MSA................................................................................................ 37
Table 27. HIV Diagnoses and Persons Living with HIV, Atlanta Metropolitan Statistical Area1, Georgia, 2020 ........... 37 Late Diagnoses by Public Health District and Atlanta MSA .............................................................................................. 38
Table 28. Late diagnoses by Public Health District and for Atlanta Metropolitan Statistical Area, Georgia, 2020 ...... 38 Public Health District and County Rates ........................................................................................................................... 39
Table 29. HIV diagnoses and persons living with HIV (PLWH): Public Health District and County number and rates per 100,000 population, Georgia 2020 ......................................................................................................................... 39 Distribution of General Population by Race/Ethnicity...................................................................................................... 43 Table 30. Distribution of the general population by race/ethnicity, Georgia 2020...................................................... 43 HIV/AIDS RESOURCES: .......................................................................................................................................................... 44
2020 Georgia HIV Surveillance Summary
Page 4
INTRODUCTION
HIV infection remains an important public health problem in the state of Georgia. As of the end of 2020, there were 60,073 persons living with HIV in Georgia, and 2,018 persons were diagnosed in 2020. The number of persons living with HIV continues to increase, because of effective therapies now available. Based on the Centers for Disease Control and Prevention's 2019 HIV Surveillance Report, Georgia was ranked the fourth highest in the nation for both the total number of new diagnoses of HIV infection among adults and adolescents after Florida, California, and Texas, and ranked the fifth highest for the number of persons living with HIV infection, after Florida, California, Texas, and New York1. Georgia ranked 2nd in the rate of HIV diagnosis among adults and adolescents, and 4th in the rate of persons living with HIV.
Monitoring the HIV/AIDS epidemic and understanding the burden of HIV infection in Georgia are essential for meeting the goals stated in the 2022-2025 National HIV/AIDS Strategy to: 1) prevent new HIV infections; 2) improve HIV-related health outcomes for persons living with HIV; 3) reduce HIV-related health disparities and inequities, and 4) achieve a more coordinated national response to the HIV epidemic among all partners and stakeholders.2
Information on the Georgia HIV care continuum can be found in a separate report at the following web page: https://dph.georgia.gov/hiv-care-continuum.
Interpreting HIV Surveillance Data During the COVID-19 Pandemic
After the COVID-19 pandemic was declared a national and state emergency in March 2020, access to healthcare services, including HIV testing, prevention, and care-related services, became reduced or temporarily suspended. Therefore, decreases seen in 2020 HIV diagnoses may partly represent decreased availability of HIV testing or delays in seeking HIV testing. As a result, 2020 HIV surveillance data should be interpreted with caution.
2020 Georgia HIV Surveillance Summary
Page 5
TECHNICAL NOTES
Georgia statutes and regulations (O.C.G.A. 3112-2(b)) require healthcare providers (such as nurses, nurse practitioners, doctors, physician assistants) licensed in the state of Georgia to report all cases of HIV infection and/or Stage 3 (AIDS) to the Georgia DPH within seven days of diagnosis3. Laboratories licensed in the state of Georgia are required to report all HIV-related laboratory test results within 7 days. The information is used to monitor the HIV/AIDS epidemic in Georgia and guide program planning and evaluation. The data presented in the accompanying tables are based on confidential case reports collected through the Georgia DPH enhanced HIV/AIDS Reporting System (eHARS).
AIDS reporting began in the early 1980s, and HIV reporting began in Georgia on December 31, 2003. Electronic transmission of laboratory test results began in 2011. Receipt of CD4 counts and viral load tests make it possible to estimate the HIV Care Continuum for persons with a diagnosis of HIV infection in the state of Georgia (reports are available at: https://dph.georgia.gov/hiv-carecontinuum).
This report includes surveillance data reported through December 31, 2021 for cases diagnosed through December 31, 2020. This report is limited to cases diagnosed through December 2020 to take into account delays in reporting, and to allow for obtaining follow up information on reported cases.
2020 Georgia HIV Surveillance Summary
HIV diagnoses include persons with a diagnosis of HIV infection, regardless of the stage of disease at diagnosis, who were residents of Georgia at the time of diagnosis. Persons living with HIV are those with a residence in the state of Georgia, based on current information available in the Georgia HIV/AIDS surveillance system, regardless of where they resided at the time of diagnosis. Persons residing in correctional facilities are included in this report and may inflate rates in certain geographic regions where there are large numbers of HIV-positive inmates.
Information on transmission category is missing for one quarter of cases. Multiple imputation, a statistical approach, is used to replace each missing transmission category with a set of plausible values that represent the uncertainty about the true, but missing, value4. The methods were applied to adult and adolescent, but not pediatric cases. Multiple imputation is considered by the Centers for Disease Control and Prevention to be the best method for redistribution of missing data in large databases. Transmission category is shown with missing data, and after multiple imputation. Cases missing race/ethnicity are not assigned a risk through multiple imputation.
Persons for whom the current identity box "transgender" was checked on the case report form are classified as transgender. Because providers often do not complete all case report form fields, the numbers
Page 6
reported here are most likely an underestimate. Additionally, because the current identity fields were added to the case report form in 2007, prevalent counts of HIV among transgender persons may be incomplete.
Persons with transmission category "perinatal/other pediatric" include infants born in Georgia who acquired HIV through perinatal transmission, as well as infants born outside of Georgia who acquired HIV through perinatal transmission and were first diagnosed with HIV in Georgia. For more information on perinatal HIV exposure surveillance in Georgia, see the Perinatal HIV Exposure Surveillance Report at https://dph.georgia.gov/epidemiology/georgias-hivaidsepidemiology-section/georgia-hiv-surveillance-data.
For data presented at the Public Health District or MSA level, all cells with values between 1 and 4 observations are censored in accordance with the Georgia Department of Public Health HIV Surveillance Security and Confidentiality Guidelines.
Definitions
HIV DIAGNOSES are cases diagnosed between January 1 and December 31, 2020, with an address at the time of HIV diagnosis was in Georgia, and who were reported to the Georgia Department of Public Health by December 31, 2020, regardless of stage at diagnosis. This group includes persons whose initial diagnosis is Stage 3 (AIDS).
LATE DIAGNOSES are the subset of HIV diagnoses who
2020 Georgia HIV Surveillance Summary
are found to be Stage 3 (AIDS) within 12 months of HIV diagnosis date. Such persons are termed late diagnoses because their advanced stage at diagnosis indicates that they were most likely infected for many years before diagnosis.
STAGE 3 (AIDS) DIAGNOSES include two groups: 1) persons newly diagnosed with HIV in 2020, found to meet the definition for Stage 3 (AIDS) at diagnosis, and with an address at or near the time of Stage 3 diagnosis in Georgia; and, 2) persons found to meet the Stage 3 definition in 2020 with an address at or near the time of Stage 3 diagnosis in Georgia, regardless of the date of their initial HIV diagnosis.
PERSONS LIVING WITH HIV INFECTION are persons diagnosed by December 31, 2020, who are not known to be deceased, and for whom the most recent address available is in Georgia.
PERSONS LIVING WITH HIV, EVER STAGE 3 are persons diagnosed by December 31, 2020, who are not known to be deceased, for whom the most recent address available is in Georgia, and who met the case definition for Stage 3 (AIDS) at some point.
TRANSMISSION CATEGORIES presented in this report follow the standards created by the Centers for Disease Control and Prevention (CDC) and have been used for many years. According to the CDC, transmission category is the term for the classification of cases that summarizes a person's possible HIV risk factors. The summary classification results from selecting the one most likely risk factor to have been responsible for HIV
Page 7
transmission from the presumed hierarchical order of probability. For surveillance purposes, HIV and AIDS cases are counted only once in the hierarchy of transmission categories. Persons with more than one reported risk factor for HIV infection are classified in the transmission category according to the behavior that is most likely to have resulted in transmission. The exception is men who report sexual contact with other men and injection drug use; this group makes up a separate transmission category. Persons whose transmission category is classified as heterosexual contact are persons who report heterosexual contact specifically with a person known to have or be at high risk for HIV infection (e.g., an injection drug user/IDU). The term high risk is not included in the transmission category label for heterosexual contact in the tables because heterosexual contact itself is the risk factor most likely to have been responsible for transmission. However, the Table 3 footnote regarding this category clarifies how the data are defined: "heterosexual contact with a person known to have, or to be at high risk for, HIV infection".
CURRENT RESIDENCE Current address is determined using the date of the most recently-entered residential address as of 12/31/2020 into the Georgia eHARS. The number of persons living with HIV is based on current address.
VITAL STATUS: Persons are assumed to be alive unless otherwise documented or reported. The Georgia DPH performs an annual match of the eHARS database with the Georgia Vital Records death data, the National Death Index and the Social Security Death Index to ascertain vital status.
2020 Georgia HIV Surveillance Summary
RATES: Denominators for population rates are based on the 2020 estimates of the Georgia resident population retrieved from the Georgia Department of Public Health, Office of Health Indicators for Planning (OHIP). Rates are per 100,000 population. Rates are not presented for case numbers less than 12 because these rates have relative standard errors greater than 30% and are considered unreliable.
PERCENTAGES: Total percentages may not add up to 100% due to rounding.
COUNTS: Counts in the gender, race/ethnicity, and age categories may not add up to the overall totals due to a small number of cases with missing information (<2 percent).
References
1. Centers for Disease Control and Prevention. HIV Surveillance Report, 2019; vol.32. http://www.cdc.gov/hiv/library/reports/hivsurveillance.html. Published May 2021.
2. White House Office of National AIDS Policy. National HIV/AIDS Strategy (2022-2025). https://hivgov-prodv3.s3.amazonaws.com/s3fs-public/NHAS-20222025.pdf. Published 2021.
3. Department of Public Health, Rules and regulations 290-48.11 (2003); Official Code of Georgia Annotated (O.C.G.A.) 31-22-9.2 (2011)
Page 8
4. Harrison KM, Kajese T, Hall HI, Song R. Risk factor redistribution of the national HIV/AIDS surveillance data: an alternative approach. Public Health Rep 2008;123:61827.
2020 Georgia HIV Surveillance Summary
Page 9
TABLES
2020 Georgia HIV Surveillance Summary
Page 10
HIV Diagnoses and persons living with HIV, Georgia, 2020
Table 1. HIV diagnoses, late diagnoses, and stage 3 (AIDS) diagnoses, Georgia, 2020
Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing
HIV Diagnoses (all stages)
Total
N
%*
2,016
100
Gender Identity
Cisgender Male
1,548
76.7
Cisgender Female
409
20.3
Transgender Persons
59
2.9
Race/Ethnicity
Black/Non Hispanic
1,457
72.2
White/Non Hispanic
321
15.9
Hispanic/Latino, Any Race
177
8.8
American Indian/Alaska Native
2
0.1
Asian/Native Hawaiian/Pacific Islander
17
0.8
Multiple races
20
1.0
Age Group at Diagnosis (Years)
<13
2
0.1
13-19
100
5.0
20-29
815
40.4
30-39
561
27.8
40-49
257
12.7
50-59
204
10.1
60+
79
3.9
Transmission Category (Unadjusted)
Male-to-male sexual contact
1,126
55.8
Injection drug use
35
1.7
Male-to-male sexual contact and injection drug use
27
1.3
Heterosexual contact3
364
18.0
Perinatal/other pediatric4
0
0.0
Unknown
466
23.1
Transmission Category (Adjusted)5
Male-to-male sexual contact
1,356
67.2
Injection drug use
64
3.2
Male-to-male sexual contact and injection drug use
35
1.7
Heterosexual contact3
539
26.7
Perinatal/other pediatric4
0
0.0
Late HIV Diagnoses1
N
%*
460
100
row %
22.8
Stage 3 (AIDS) Diagnoses2
N
%*
1,088
100
342
74.3
22.1
821
75.4
103
22.4
25.2
235
21.6
15
3.3
25.4
32
2.9
325
70.7
22.3
799
73.4
73
15.9
22.7
158
14.5
46
10.0
26.0
91
8.4
1
0.2
50.0
1
0.1
9
2.0
52.9
14
1.3
1
0.2
5.0
19
1.7
0
0.0
0.0
0
0.0
9
2.0
9.0
11
1.0
134
29.1
16.4
257
23.6
128
27.8
22.8
321
29.5
93
20.2
36.2
229
21.0
69
15.0
33.8
179
16.4
27
5.9
34.2
92
8.4
222
48.3
19.7
539
49.5
4
0.9
11.4
32
2.9
4
0.9
14.8
24
2.2
108
23.5
29.7
224
20.6
0
0.0
1
0.1
122
26.5
26.2
268
24.6
280
60.8
20.6
668
61.3
13
2.8
20.3
50
4.6
6
1.3
17.1
30
2.8
156
34.0
28.9
329
30.2
0
0.0
1
0.1
*Percentages may not add up to 100% due to rounding. 1. Late diagnosis: stage 3 (AIDS) diagnosis within 12 months of HIV diagnosis. Row % is percent of HIV diagnoses that were late diagnoses 2. Stage 3 (AIDS): includes persons diagnosed with stage 3 in 2020, regardless of year of HIV diagnosis. 3. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with. hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 4. Perinatal/other pediatric: cases <13 born to HIV-infected mother, cases <13 with missing risk, and cases <13 with other risk (e.g. sexual transmission). 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding.
2020 Georgia HIV Surveillance Summary
Page 11
Table 2. HIV diagnoses, late diagnoses, and stage 3 (AIDS) diagnoses among Cis-Gender Males, Georgia, 2020
Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing
Total Race/Ethnicity
Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races
Age Group at Diagnosis (Years)
<13 13-19 20-29 30-39 40-49 50-59 60+
Transmission Category (Unadjusted)
Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact3 Perinatal/other pediatric4 Unknown
Transmission Category (Adjusted)5
Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact3 Perinatal/other pediatric4
HIV Diagnoses (all stages)
N
1,546
%*
100.0
1,103
71.3
240
15.5
153
9.9
2
0.1
11
0.7
17
1.1
1
0.1
75
4.8
675
43.6
448
28.9
164
10.6
139
9.0
46
3.0
1,069
69.1
21
1.4
26
1.7
125
8.1
0
0.0
307
19.8
1,299
83.9
33
2.1
34
2.2
161
10.4
0
0.0
Late HIV Diagnoses1
Stage 3 (AIDS) Diagnoses2
N
%* row %
342
100.0
22.1
N %*
821 100.0
240
70.2
50
14.6
40
11.7
1
0.3
5
1.5
1
0.3
21.8
595 72.5
20.8
120 14.6
26.1
74
9.0
50.0
1
0.1
45.5
10
1.2
5.9
15
1.8
0
0.0
8
2.3
112
32.7
101
29.5
61
17.8
48
14.0
12
3.5
0.0
0
0.0
10.7
9
1.1
16.6
212 25.8
22.5
260 31.7
37.2
151 18.4
34.5
126 15.3
26.1
63
7.7
207
60.5
2
0.6
4
1.2
48
14.0
0
0.0
81
23.7
19.4
508 61.9
9.5
21
2.6
15.4
23
2.8
38.4
90 11.0
0
0.0
26.4
178 21.7
265
77.4
6
1.7
6
1.8
60
17.6
0
0.0
20.4
637 77.6
18.2
29
3.6
17.6
29
3.6
37.3
117 14.2
0
0.0
* Percentages may not add up to 100% due to rounding. 1. Late diagnosis: stage 3 (AIDS) diagnosis within 12 months of HIV diagnosis. Row % is percent of HIV diagnoses that were late diagnoses 2. Stage 3 (AIDS): includes persons diagnosed with stage 3 in 2020, regardless of year of HIV diagnosis. 3. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with. hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 4. Perinatal/other pediatric: cases born to HIV-infected mother, cases <13 with missing risk, and cases <13 with other risk (e.g. sexual transmission). 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding.
2020 Georgia HIV Surveillance Summary
Page 12
Table 3. HIV diagnoses, late diagnoses, and stage 3 (AIDS) diagnoses among Cis-Gender Females, Georgia, 2020
Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing
Total
Race/Ethnicity
Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races
Age Group at Diagnosis (Years)
<13 13-19 20-29 30-39 40-49 50-59 60+
Transmission Category (Unadjusted)
Injection drug use Heterosexual contact3 Perinatal/other pediatric4 Unknown
Transmission Category (Adjusted)5
Injection drug use Heterosexual contact3 Perinatal/other pediatric4
HIV Diagnoses (all stages)
N
%*
407
100.0
Late HIV Diagnoses1
N
%*
row %
103 100.0
25.3
Stage 3 (AIDS) Diagnoses2
N
%*
234
100.0
308
75.3
75
72.8
24.4
180
76.6
71
17.4
20
19.4
28.2
34
14.5
19
4.6
4
3.9
21.1
12
5.1
0
0.0
0
0.0
0
0.0
6
1.5
4
3.9
66.7
4
1.7
3
0.7
0
0.0
0.0
4
1.7
1
0.2
0
0.0
0.0
22
5.4
0
0.0
0.0
104
25.4
15
14.6
14.4
96
23.5
21
20.4
21.9
88
21.5
31
30.1
35.2
65
15.9
21
20.4
32.3
33
8.1
15
14.6
45.5
0
0.0
1
0.4
29
12.3
51
21.7
74
31.5
51
21.7
29
12.3
14
3.4
2
1.9
14.3
11
4.7
238
58.2
60
58.3
25.2
134
57.0
0
0.0
0
0.0
1
0.4
157
38.4
41
39.8
26.1
89
37.9
31
7.5
7
6.6
22.6
21
8.9
375
91.8
96
93.4
25.6
212
90.3
0
0.0
0
0.0
1
0.4
* Percentages may not add up to 100% due to rounding. 1. Late diagnosis: stage 3 (AIDS) diagnosis within 12 months of HIV diagnosis. Row % is percent of HIV diagnoses that were late diagnoses 2. Stage 3 (AIDS): includes persons diagnosed with stage 3 in 2020, regardless of year of HIV diagnosis. 3. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with. hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 4. Perinatal/other pediatric: cases born to HIV-infected mother, cases <13 with missing risk, and cases <13 with other risk (e.g. sexual transmission). 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding.
2020 Georgia HIV Surveillance Summary
Page 13
Table 4. HIV diagnoses, late diagnoses, and stage 3 (AIDS) diagnoses among Transgender Persons, Georgia, 2020
Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing
HIV Diagnoses (all stages)
Late HIV Diagnoses1
Stage 3 (AIDS) Diagnoses2
Total
N
%*
59
100.0
N
%*
15 100.0
row %
25.4
N
%*
32
100.0
Gender Identity
Transgender Woman Transgender Man
Race/Ethnicity
Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races
Age Group at Diagnosis (Years)
13-19 20-29 30-39 40-49 50-59 60+
Transmission Category (Unadjusted)
Sexual contact3 Sexual contact and injection drug use Unknown
Transmission Category (Adjusted)4
Sexual contact3 Sexual contact and injection drug use Injection drug use
57
96.6
15 100.0
26.3
2
3.4
0
0.0
0.0
45
76.3
10
66.7
22.2
9
15.3
3
20.0
33.3
5
8.5
2
13.3
40.0
0
0.0
0
0.0
--
0
0.0
0
0.0
--
0
0.0
0
0.0
--
2
3.4
1
6.7
50.0
35
59.3
7
46.7
20.0
17
28.8
6
40.0
35.3
5
8.5
1
6.7
20.0
0
0.0
0
0.0
0
0.0
0
0.0
57
96.5
15 100.0
26.3
1
1.7
0
0.0
0.0
1
1.7
0
0.0
0.0
28
98.3
15 100.0
1
1.7
0
0.0
0
0.0
0
0.0
0.0
32
100.0
0
0.0
24
75.0
4
12.5
4
12.5
0
0.0
0
0.0
0
0.0
1
3.1
15
46.9
10
31.3
4
12.5
2
6.3
0
0.0
31
96.9
1
3.1
0
0.0
31
96.9
1
3.1
0
0.0
1. Late diagnosis: stage 3 (AIDS) diagnosis within 12 months of HIV diagnosis. 2. Stage 3 (AIDS): includes persons diagnosed with stage 3 in 2020, regardless of year of HIV diagnosis. 3. Includes sex with male and probable heterosexual transmission as noted in medical chart. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding.
2020 Georgia HIV Surveillance Summary
Page 14
Table 5. Persons Living with HIV (PLWH), and PLWH ever Stage 3 (AIDS), Georgia, as of 12/31/2020
Total Gender Identity
Cisgender Male Cisgender Female Transgender Persons
Race/Ethnicity
Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races
Current Age Group (Years)
<13 13-19 20-29 30-39 40-49 50-59 60+
Transmission Category (Unadjusted)
Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact2 Adult Other3 Perinatal/other pediatric4 Unknown
Transmission Category (Adjusted)5
Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact2 Adult Other3 Perinatal/other pediatric4
PLWH N
59,949
%*
100.0
45,156
75.2
14,110
23.5
683
1.1
40,999
68.2
10,462
17.4
4,516
7.5
28
0.0
320
0.5
2,785
4.6
81
0.1
302
0.5
6,710
11.2
14,088
23.5
12,627
21.0
15,792
26.3
10,461
17.4
30,440
50.7
2,294
3.8
1,877
3.1
10,058
16.7
569
0.9
73
0.1
14,762
24.6
37,044
61.7
3,360
5.6
2,314
3.9
15,739
26.2
569
0.9
73
0.1
Ever Stage 3 (AIDS)1
N
%*
30,134
100.0
22,612
74.9
7,211
23.9
311
1.0
20,908
69.3
5,121
17.0
2,266
7.5
11
0.0
118
0.4
1,588
5.3
22
0.1
44
0.1
1,556
5.2
5,362
17.8
6,679
22.1
9,762
32.4
6,748
22.4
14,691
48.7
1,608
5.3
1,207
4.0
5,616
18.6
289
1.0
20
0.1
6,744
22.4
17,696
58.6
2,214
7.3
1,451
4.8
8,338
27.6
289
1.0
20
0.1
* Percentages may not add up to 100% due to rounding. 1. Persons whose infection was ever classified as stage 3 (AIDS). 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure current age > 13, hemophilia, blood transfusion. 4. Perinatal/other pediatric: cases<13 born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods.
2020 Georgia HIV Surveillance Summary
Page 15
Table 6. Persons living with HIV (PLWH), and PLWH ever stage 3 (AIDS), Cis-Gender Males, Georgia, as of 12/31/2020
Total Race/Ethnicity
Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races
Current Age Group (Years)
<13 13-19 20-29 30-39 40-49 50-59 60+
Transmission Category (Unadjusted)
Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact2 Adult Other3 Perinatal/other pediatric4 Unknown
Transmission Category (Adjusted)5
Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact2 Adult Other3 Perinatal/other pediatric4
N
44,459
PLWH
%*
100.0
29,545
65.4
8,910
19.7
3,616
8.0
24
0.1
239
0.5
2,125
4.7
39
0.1
203
0.5
5,579
12.4
11,290
25.0
8,885
19.7
11,714
25.9
7,439
16.5
29,800
66.0
1,271
2.8
1,848
4.1
2,719
6.0
273
0.6
34
0.1
9,211
20.4
36,389
80.6
1,728
3.8
2,284
5.1
3,763
8.3
273
0.6
34
0.1
Ever Stage 3 (AIDS)1
N
%*
22,488
100.0
14,951
66.1
4,415
19.5
1,818
8.0
8
0.0
94
0.4
1,202
5.3
12
0.1
27
0.1
1,261
5.6
4,308
19.1
4,742
21.0
7,338
32.5
4,923
21.8
14,407
63.7
923
4.1
1,190
5.3
1,675
7.4
139
0.6
10
0.0
4,268
18.9
17,404
77.0
1,199
5.3
1,433
6.3
2,304
10.2
139
0.6
10
0.0
* Percentages may not add up to 100% due to rounding. 1. Persons whose infection was ever classified as stage 3 (AIDS). 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure current age > 13, hemophilia, blood transfusion. 4. Perinatal/other pediatric: cases <13 born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods.
2020 Georgia HIV Surveillance Summary
Page 16
Table 7. Persons living with HIV (PLWH), and PLWH ever stage 3 (AIDS), Cis-Gender Females, Georgia, as of 12/31/2020
Total Race/Ethnicity
Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races
Current Age Group (Years)
<13 13-19 20-29 30-39 40-49 50-59 60+
Transmission Category (Unadjusted)
Injection drug use Heterosexual contact2 Adult Other3 Perinatal/other pediatric4 Unknown
Transmission Category (Adjusted)5
Injection drug use Heterosexual contact2 Adult Other3 Perinatal/other pediatric4
PLWH
N
13,892
%*
100.0
10,860
77.0
1,504
10.7
820
5.8
4
0.0
81
0.6
623
4.4
42
0.3
96
0.7
956
6.8
2,468
17.5
3,584
25.4
3,978
28.2
2,981
21.1
1,017
7.2
7,317
51.9
291
2.1
39
0.3
5,446
38.6
1,623
11.5
11,935
84.6
291
2.1
39
0.3
Ever Stage 3 (AIDS)1
N
7,182
%*
100.0
5,688
78.9
692
9.6
406
5.6
3
0.0
24
0.3
369
5.1
10
0.1
16
0.2
247
3.4
920
12.8
1,853
25.7
2,366
32.8
1,798
24.9
682
9.5
3,932
54.5
146
2.0
10
0.1
2,441
33.9
1,010
14.0
6,015
83.4
146
2.0
10
0.1
* Percentages may not add up to 100% due to rounding. 1. Persons whose infection was ever classified as stage 3 (AIDS). 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure current age > 13, hemophilia, blood transfusion. 4. Perinatal/other pediatric: cases <13 born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods.
2020 Georgia HIV Surveillance Summary
Page 17
Table 8. Persons living with HIV (PLWH), and PLWH ever stage 3 (AIDS), Transgender Persons, Georgia, as of 12/31/2020
Total Gender Identity
Transgender Woman Transgender Man
Race/Ethnicity
Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races
Current Age Group (Years)
13-19 20-29 30-39 40-49 50-59 60+
Transmission Category (Unadjusted)
Sexual contact2 Injection drug use Sexual contact and injection drug use Adult Other3 Unknown
Transmission Category (Adjusted)4
Sexual contact2 Injection drug use Sexual contact and injection drug use Adult Other3
PLWH N
683
653 30
538 39 73 0 0 33
2 163 298 126 72 22
634 3 27 4 26
647 5 28 4
%*
100.0
95.6 4.4
78.8 5.7 10.7 0.0 0.0 4.8
0.3 23.9 43.6 18.4 10.5 3.2
91.2 0.4 4.0 0.6 3.8
94.6 0.7 4.1 0.6
Ever Stage 3 (AIDS)1
N
%*
311
100.0
298
95.8
13
4.2
244
78.5
13
4.2
39
12.5
0
0.0
0
0.0
15
4.8
1
0.3
45
14.5
126
40.5
73
23.5
49
15.8
17
5.5
280
90.1
1
0.3
16
5.1
3
1.0
11
3.5
290
93.2
2
0.6
16
5.3
3
1.0
* Percentages may not add up to 100% due to rounding. 1. Persons whose infection was ever classified as stage 3 (AIDS). 2. Includes sex with male and probable heterosexual transmission as noted in medical chart 3. Includes perinatal exposure current age > 13, hemophilia, blood transfusion.4. Adjusted for missing risk using multiple imputation methods.
2020 Georgia HIV Surveillance Summary
Page 18
HIV Diagnoses and Persons Living with HIV by Public Health District
Table 9. HIV Diagnoses and Persons Living with HIV, District 1-1 (Rome), Georgia, 2020
Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing
Total
Gender Identity
Cisgender Male
HIV diagnoses N
53
%*
100.0
38
71.7
PLWH as of 12/31/2020
N
%*
1,239
100.0
896
72.3
Cisgender Female
14
26.4
339
27.4
Transgender Woman
<5
<5
Transgender Man
0
0.0
0
0.0
Race/Ethnicity
Black/Non Hispanic
28
52.8
506
40.8
White/Non Hispanic
21
39.6
557
45.0
Hispanic/Latino, Any Race
<5
104
8.4
American Indian/Alaska Native
0
0.0
0
0.0
Asian/Native Hawaiian/Pacific Islander
0
0.0
5
0.4
Multiple races
0
0.0
48
3.9
Age Group (at diagnosis for diagnosed,
current for PLWH)
<13
0
0.0
<5
--
13-19
<5
--
9
0.7
20-29
19
35.8
115
9.3
30-39
13
24.5
216
17.4
40-49
8
15.1
282
22.8
50-59
8
15.1
353
28.5
60+
<5
--
263
21.2
Transmission Category (Unadjusted)
Male-to-male sexual contact
23
43.4
515
41.6
Injection drug use
<5
--
92
7.4
Male-to-male sexual contact and injection drug use
<5
Heterosexual contact1
12
Adult Other2
0
Perinatal/other pediatric3
0
--
65
5.2
22.6
206
16.6
0.0
20
1.6
0.0
<5
--
Unknown Transmission Category (Adjusted)4
13
24.5
340
27.4
Male-to-male sexual contact
30
57.4
669
54.0
Injection drug use
<5
--
119
9.6
Male-to-male sexual contact and injection drug use
<5
Heterosexual contact1
17
Adult Other2
0
Perinatal/other pediatric3
0
--
78
6.3
32.5
333
26.9
0.0
20
1.6
0.0
<5
--
* Percentages may not add up to 100% due to rounding 1. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 2. Includes perinatal exposure current age > 13; hemophilia, blood transfusion.3. Perinatal/other pediatric: cases <13 born to HIV-infected mother, and cases <13 with missing risk. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding
2020 Georgia HIV Surveillance Summary
Page 19
Table 10. HIV Diagnoses and Persons Living with HIV, District 1-2 (Dalton), Georgia, 2020
Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing
Total Gender Identity
Cisgender Male Cisgender Female Transgender Woman Transgender Man
Race/Ethnicity
Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races
Age Group (at diagnosis for diagnosed, current for PLWH)
<13 13-19 20-29 30-39 40-49 50-59 60+
Transmission Category (Unadjusted)
Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown
Transmission Category (Adjusted)3
Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric4
HIV diagnoses
N
%*
23
100.0
17
73.9
<5
--
<5
--
0
0.0
<5
--
15
65.2
5
21.7
0
0.0
0
0.0
0
0.0
0
0.0
<5
--
8
34.8
9
39.1
<5
--
<5
--
0
0.0
13
56.5
<5
--
<5
--
<5
--
0
0.0
0
0.0
<5
--
14
59.1
<5
--
<5
--
5
22.2
0
0.0
0
0.0
PLWH as of 12/31/2020
N
%*
722
100.0
566
78.4
147
20.4
5
0.7
0
0.0
136
18.8
407
56.4
127
17.6
0
0.0
<5
--
35
4.8
0
0.0
<5
--
72
10.0
122
16.9
175
24.2
202
28.0
148
20.5
366
50.7
33
4.6
48
6.6
100
13.9
<5
--
0
0.0
171
23.7
447
62.0
46
6.3
54
7.5
156
21.6
<5
--
0
0.0
* Percentages may not add up to 100% due to rounding 1. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known
risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV
documentation, and or person with AIDS or documented HIV. 2. Includes perinatal exposure current age > 13; hemophilia, blood transfusion. 3.
Perinatal/other pediatric: cases <13 born to HIV-infected mother, and cases <13 with missing risk. 4. Adjusted for missing risk using multiple imputation
202m0etGhoedos.rAgdiajusHteIdVsuSbutorvtaelsilmlaany cbeedSifufemrenmt farormy unadjusted subtotals due to rounding
Page 20
Table 11. HIV Diagnoses and Persons Living with HIV, District 2 (Gainesville), Georgia, 2020
Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing
Total Gender Identity Cisgender Male Cisgender Female Transgender Woman Transgender Man Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races Age Group (at diagnosis for diagnosed, current for PLWH) <13 13-19 20-29 30-39 40-49 50-59 60+ Transmission Category (Unadjusted) Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown Transmission Category (Adjusted)4 Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3
HIV diagnoses
N
%*
48
100.0
33
68.8
13
27.1
<5
--
0
0.0
18
37.5
18
37.5
6
12.5
0
0.0
<5
--
<5
--
0
0.0
<5
--
20
41.7
9
18.8
<5
--
8
16.7
<5
--
24
50.0
<5
--
<5
--
8
16.7
0
0.0
0
0.0
14
29.2
31
64.0
<5
--
<5
--
13
27.5
0
0.0
0
0.0
PLWH as of 12/31/2020
N
%*
963
100.0
679
70.5
273
28.3
9
0.9
0
0.0
240
24.9
471
48.9
150
15.6
<5
22
2.3
53
5.5
0
0.0
<5
0.4
97
10.1
173
18.0
224
23.3
286
29.7
179
18.6
404
42.0
41
4.3
49
5.1
158
16.4
9
0.9
0
0.0
302
31.4
534
55.5
64
6.7
58
6.0
272
28.3
9
0.9
0
0.0
* Percentages may not add up to 100% due to rounding 1. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 2. Includes perinatal exposure current age > 13; hemophilia, blood transfusion.3. Perinatal/other pediatric: cases <13 born to HIV-infected mother, and cases <13 with missing risk. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding
2020 Georgia HIV Surveillance Summary
Page 21
Table 12. HIV Diagnoses and Persons Living with HIV, District 3-1 (Cobb/Douglas), Georgia, 2020
Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing
HIV diagnoses
PLWH as of 12/31/2020
Total Gender Identity Cisgender Male Cisgender Female Transgender Woman Transgender Man Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races
N
%*
N
%*
160
100.0
4,311
100.0
126
78.8
3,296
76.5
29
18.1
957
22.2
5
3.1
49
1.1
0
0.0
<5
107
66.9
2,719
63.1
34
21.3
844
19.6
15
9.4
455
10.6
0
0.0
<5
--
<5
--
17
0.4
<5
--
224
5.2
Age Group (at diagnosis for diagnosed, current for PLWH)
<13
0
0.0
5
0.1
13-19
5
3.1
12
0.3
20-29
69
43.1
539
12.5
30-39
56
35.0
1,134
26.3
40-49
19
11.9
961
22.3
50-59
7
4.4
1,064
24.7
60+
<5
--
595
13.8
Transmission Category (Unadjusted)
Male-to-male sexual contact
92
57.5
2,358
54.7
Injection drug use
<5
--
122
2.8
Male-to-male sexual contact and injection drug use
<5
--
122
2.8
Heterosexual contact1
26
16.3
750
17.4
Adult Other2
0
0.0
40
0.9
Perinatal/other pediatric3
0
0.0
5
0.1
Unknown
37
23.1
914
21.2
Transmission Category (Adjusted)4
Male-to-male sexual contact
113
70.4
2,820
65.4
Injection drug use
5
2.9
184
4.3
Male-to-male sexual contact and injection drug use
<5
--
150
3.5
Heterosexual contact1
39
24.3
1,060
24.6
Adult Other2
0
0.0
40
0.9
Perinatal/other pediatric3
0
0.0
5
0.1
* Percentages may not add up to 100% due to rounding 1. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 2. Includes perinatal exposure current age > 13; hemophilia, blood transfusion.3. Perinatal/other pediatric: cases<13 born to HIV-infected mother, and cases <13 with missing risk. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding
2020 Georgia HIV Surveillance Summary
Page 22
Table 13. HIV Diagnoses and Persons Living with HIV, District 3-2 (Fulton), Georgia, 2020
Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV
testing
HIV diagnoses
PLWH as of 12/31/2020
N
%*
N
%*
Total
Gender Identity
Cisgender Male
481
100.0
16,377
404
84.0
13602
100.0 83.1
Cisgender Female
62
12.9
2520
15.4
Transgender Woman
15
3.1
211
1.3
Transgender Man
0
0.0
7
0.0
Race/Ethnicity
Black/Non Hispanic
384
79.8
11901
72.7
White/Non Hispanic
55
11.4
2494
15.2
Hispanic/Latino, Any Race
28
5.8
960
5.9
American Indian/Alaska Native
<5
--
8
0.0
Asian/Native Hawaiian/Pacific Islander
<5
--
59
0.4
Multiple races
8
1.7
739
4.5
Age Group (at diagnosis for diagnosed,
current for PLWH)
<13
0
0.0
11
0.1
13-19
18
3.7
41
0.3
20-29
195
40.5
1679
10.3
30-39
148
30.8
4178
25.5
40-49
54
11.2
3449
21.1
50-59
48
10.0
4250
26.0
60+
18
3.7
2763
16.9
Transmission Category (Unadjusted)
Male-to-male sexual contact
324
67.4
10109
61.7
Injection drug use
<5
--
620
3.8
Male-to-male sexual contact and injection drug use
8
1.7
614
3.7
Heterosexual contact1
74
15.4
1910
11.7
Adult Other2
0
0.0
97
0.6
Perinatal/other pediatric3
0
0.0
7
0.0
Unknown
72
15.0
3020
18.4
Transmission Category (Adjusted)4
Male-to-male sexual contact
362
75.3
11703
71.5
Injection drug use
7
1.5
812
5.0
Male-to-male sexual contact and injection drug use
9
2.0
721
4.4
Heterosexual contact1
98
20.4
2818
17.2
Adult Other2
0
0.0
97
0.6
Perinatal/other pediatric3
0
0.0
7
0.0
* Percentages may not add up to 100% due to rounding 1. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 2. Includes perinatal exposure current age > 13; hemophilia, blood transfusion.3. Perinatal/other pediatric: cases <13 born to HIV-infected mother, and cases <13 with missing risk. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding
2020 Georgia HIV Surveillance Summary
Page 23
Table 14. HIV Diagnoses and Persons Living with HIV, District 3-3 (Clayton), Georgia, 2020
Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing
Total Gender Identity
Cisgender Male
HIV diagnoses
N
%*
113
100.0
86
76.1
PLWH as of 12/31/2020
N
%*
3,056
100.0
2,206
72.2
Cisgender Female
24
21.2
796
26.0
Transgender Woman
<5
--
49
1.6
Transgender Man
0
0.0
<5
--
Race/Ethnicity
Black/Non Hispanic
97
85.8
2,537
83.0
White/Non Hispanic
6
5.3
117
3.8
Hispanic/Latino, Any Race
8
7.1
198
6.5
American Indian/Alaska Native
0
0.0
<5
--
Asian/Native Hawaiian/Pacific Islander
0
0.0
25
0.8
Multiple races
<5
--
146
4.8
Age Group (at diagnosis for diagnosed,
current for PLWH)
<13
0
0.0
6
0.2
13-19
<5
--
14
0.5
20-29
55
48.7
481
15.7
30-39
31
27.4
826
27.0
40-49
13
11.5
639
20.9
50-59
10
8.9
695
22.7
60+
<5
--
395
12.9
Transmission Category (Unadjusted)
Male-to-male sexual contact
67
59.3
1,616
52.9
Injection drug use
<5
--
91
3.0
Male-to-male sexual contact and injection drug
0
0.0
70
2.3
use
Heterosexual contact1
21
18.6
560
18.3
Adult Other2
0
0.0
35
1.1
Perinatal/other pediatric3
0
0.0
6
0.2
Unknown
Transmission Category (Adjusted)4
Male-to-male sexual contact
24
21.2
678
22.2
79
70.0
1,904
62.3
Injection drug use
<5
--
135
4.4
Male-to-male sexual contact and injection drug
<5
--
87
2.9
use
Heterosexual contact1
29
26.0
861
28.2
Adult Other2
0
0.0
35
1.1
Perinatal/other pediatric3
0
0.0
6
0.2
* Percentages may not add up to 100% due to rounding 1. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 2. Includes perinatal exposure current age > 13; hemophilia, blood transfusion.3. Perinatal/other pediatric: cases <13 born to HIV-infected mother, and cases <13 with missing risk. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding
2020 Georgia HIV Surveillance Summary
Page 24
Table 15. HIV Diagnoses and Persons Living with HIV, District 3-4 (East Metro), Georgia, 2020
Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing
HIV diagnoses
PLWH as of 12/31/2020
Total Gender Identity
Cisgender Male
N
%*
N
%*
253
100
4,368
100
202
79.8
3,131
71.7
Cisgender Female
49
19.4
1,187
27.2
Transgender Woman
<5
--0
39
0.9
Transgender Man
0
0.0
<5
--
Race/Ethnicity
Black/Non Hispanic
152
60.1
2,658
60.9
White/Non Hispanic
28
11.1
705
16.1
Hispanic/Latino, Any Race
60
23.7
652
14.9
American Indian/Alaska Native
0
0.0
0
0.0
Asian/Native Hawaiian/Pacific Islander
5
2.0
68
1.6
Multiple races
<5
--
205
4.7
Age Group (at diagnosis for diagnosed,
current for PLWH)
<13
0
0.0
6
0.1
13-19
9
4.5
24
0.6
20-29
86
43.0
576
13.5
30-39
54
27.0
897
21.0
40-49
23
11.5
1,109
26.0
50-59
19
9.5
1,161
27.2
60+
9
4.5
498
11.7
Transmission Category (Unadjusted)
Male-to-male sexual contact
108
54.0
2,012
47.1
Injection drug use
<5
--
136
3.2
Male-to-male sexual contact and injection
<5
--
115
2.7
drug use
Heterosexual contact1
22
11.0
765
17.9
Adult Other2
0
0.0
58
1.4
Perinatal/other pediatric3
0
0.0
6
0.1
Unknown
63
31.5
1,179
27.6
Transmission Category (Adjusted)4
Male-to-male sexual contact
133
66.7
2,527
59.2
Injection drug use
8
4.1
218
5.1
Male-to-male sexual contact and injection
<5
--
151
3.5
drug use
Heterosexual contact1
53
26.4
1,236
28.9
Adult Other2
0
0.0
58
1.4
Perinatal/other pediatric3
0
0.0
6
0.1
* Percentages may not add up to 100% due to rounding 1. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 2. Includes perinatal exposure current age > 13; hemophilia, blood transfusion.3. Perinatal/other pediatric: cases <13 born to HIV-infected mother, and cases <13 with missing risk. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding
2020 Georgia HIV Surveillance Summary
Page 25
Table 16. HIV Diagnoses and Persons Living with HIV, District 3-5 (DeKalb), Georgia, 2020
Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing
Total Gender Identity
Cisgender Male Cisgender Female Transgender Woman Transgender Man
Race/Ethnicity
Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races
Age Group (at diagnosis for diagnosed, current for PLWH)
<13 13-19 20-29 30-39 40-49 50-59 60+
Transmission Category (Unadjusted)
Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown
Transmission Category (Adjusted)4
Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3
HIV diagnoses
N
%*
278
100.0
213
76.6
57
20.5
8
2.9
0
0.0
214
77.0
27
9.7
25
9.0
<5
--
<5
--
<5
--
<5
--
10
3.6
113
40.6
75
27.0
38
13.7
35
12.6
6
2.2
163
58.6
6
2.2
5
1.8
36
13.0
0
0.0
0
0.0
68
24.5
189
67.9
10
3.6
6
2.1
69
24.6
0
0.0
0
0.0
PLWH as of 12/31/2020
N
%*
9,974
100.0
7,942
79.6
1,880
18.8
127
1.3
5
0.1
7,103
71.2
1,546
15.5
701
7.0
<5
--
76
0.8
433
4.3
14
0.1
43
0.4
1,011
10.1
2,429
24.4
2,155
21.6
2,650
26.6
1,671
16.8
5,900
59.2
246
2.5
299
3.0
1,368
13.7
74
0.7
12
0.1
2,075
20.8
6,913
69.3
392
3.9
371
3.7
2,099
21.0
74
0.7
12
0.1
* Percentages may not add up to 100% due to rounding 1. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 2. Includes perinatal exposure current age > 13; hemophilia, blood transfusion.3. Perinatal/other pediatric: cases <13 born to HIV-infected mother, and cases <13 with missing risk. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding
2020 Georgia HIV Surveillance Summary
Page 26
Table 17. HIV Diagnoses and Persons Living with HIV, District 4 (LaGrange), Georgia, 2020
Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing
Total Gender Identity
Cisgender Male Cisgender Female Transgender Woman Transgender Man
Race/Ethnicity
Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races
Age Group (at diagnosis for diagnosed, current for PLWH)
<13 13-19 20-29 30-39 40-49 50-59 60+
Transmission Category (Unadjusted)
Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown
Transmission Category (Adjusted)4
Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3
HIV diagnoses
N
%*
96
100.0
74
77.1
18
18.8
<5
--
0
0.0
70
72.9
16
16.7
6
6.3
0
0.0
<5
--
<5
--
0
0.0
5
5.2
40
41.7
24
25.0
15
15.6
5
5.2
7
7.3
52
54.2
0
0.0
0
0.0
21
21.9
0
0.0
0
0.0
23
24.0
68
70.4
<5
--
<5
--
25
25.8
0
0.0
0
0.0
PLWH as of 12/31/2020
N
%*
2,529
100.0
1,821
72.0
679
26.8
25
1.0
<5
--
1,653
65.4
544
21.5
157
6.2
<5
--
7
0.3
136
5.4
5
0.2
25
1.0
321
12.7
557
22.0
519
20.5
659
26.1
442
17.5
1,154
45.6
103
4.1
74
2.9
478
18.9
33
1.3
5
0.2
682
27.0
1,455
57.5
159
6.3
96
3.8
752
29.8
33
1.3
5
0.2
* Percentages may not add up to 100% due to rounding 1. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 2. Includes perinatal exposure current age > 13; hemophilia, blood transfusion.3. Perinatal/other pediatric: cases <13 born to HIV-infected mother, and cases <13 with missing risk. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding
2020 Georgia HIV Surveillance Summary
Page 27
Table 18. HIV Diagnoses and Persons Living with HIV, District 5-1 (Dublin), Georgia, 2020
Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing
Total Gender Identity
Cisgender Male
HIV diagnoses
N
%*
16
100.0
13
81.3
PLWH as of 12/31/2020
N
%*
608
100.0
409
67.3
Cisgender Female
<5
--
195
32.1
Transgender Woman
<5
--
<5
--
Transgender Man
0
0.0
0
0.0
Race/Ethnicity
Black/Non Hispanic
15
93.8
443
72.9
White/Non Hispanic
<5
--
77
12.7
Hispanic/Latino, Any Race
0
0.0
50
8.2
American Indian/Alaska Native
0
0.0
0
0.0
Asian/Native Hawaiian/Pacific Islander
0
0.0
0
0.0
Multiple races
0
0.0
32
5.3
Age Group (at diagnosis for diagnosed,
current for PLWH)
<13
0
0.0
<5
--
<5
<5
--
20-29
7
43.8
43
7.1
30-39
<5
--
100
16.4
40-49
<5
--
138
22.7
50-59
<5
--
188
30.9
60+
<5
--
136
22.4
Transmission Category (Unadjusted)
Male-to-male sexual contact
8
50.0
149
24.5
Injection drug use
0
0.0
47
7.7
Male-to-male sexual contact and injection drug use
<5
--
20
3.3
Heterosexual contact1
<5
--
141
23.2
Adult Other2
0
0.0
<5
--
Perinatal/other pediatric3
0
0.0
<5
--
Unknown
5
31.3
246
40.5
Transmission Category (Adjusted)3
Male-to-male sexual contact
11
68.1
262
43.0
Injection drug use
<5
--
69
11.3
Male-to-male sexual contact and injection drug use
<5
--
28
4.6
Heterosexual contact1
<5
--
239
39.3
Adult Other2
0
0.0
<5
--
Perinatal/other pediatric3
0
0.0
<5
--
* Percentages may not add up to 100% due to rounding 1. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 2. Includes perinatal exposure current age > 13; hemophilia, blood transfusion. 3. Perinatal/other pediatric: cases <13 born to HIV-infected mother, and cases <13 with missing risk. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding
2020 Georgia HIV Surveillance Summary
Page 28
Table 19. HIV Diagnoses and Persons Living with HIV, District 5-2 (Macon), Georgia, 2020
Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing
Total
Gender Identity
Cisgender Male Cisgender Female Transgender Woman Transgender Man
Race/Ethnicity
Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races
Age Group (at diagnosis for diagnosed, current for PLWH)
<13 13-19 20-29 30-39 40-49 50-59 60+
Transmission Category (Unadjusted)
Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown
Transmission Category (Adjusted)4
Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3
HIV diagnoses
N
%*
83
100.0
58
69.9
25
30.1
0
0.0
0
0.0
65
78.3
14
16.9
<5
--
0
0.0
0
0.0
<5
--
0
0.0
0
0.0
32
38.6
29
34.9
13
15.7
7
8.4
<5
--
34
41.0
<5
--
<5
--
24
28.9
0
0.0
0
0.0
21
25.3
49
59.5
<5
--
<5
--
28
34.2
0
0.0
0
0.0
PLWH as of 12/31/2020
N
%*
2,332
100.0
1,587
68.1
720
30.9
19
0.8
0
0.0
1,748
75.0
343
14.7
99
4.2
<5
--
<5
--
112
4.8
<5
--
15
0.6
289
12.4
521
22.3
455
19.5
605
25.9
443
19.0
888
38.1
89
3.8
71
3.0
474
20.3
24
1.0
<5
--
782
33.5
1,233
52.9
156
6.7
91
3.9
800
34.3
24
1.0
<5
--
* Percentages may not add up to 100% due to rounding 1. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 2. Includes perinatal exposure current age > 13; hemophilia, blood transfusion.3. Perinatal/other pediatric: cases<13 born to HIV-infected mother, and cases <13 with missing risk. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding
2020 Georgia HIV Surveillance Summary
Page 29
Table 20. HIV Diagnoses and Persons Living with HIV, District 6 (Augusta), Georgia, 2020
Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing
Total Gender Identity
Cisgender Male Cisgender Female Transgender Woman Transgender Man
Race/Ethnicity
Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races
Age Group (at diagnosis for diagnosed, current for PLWH)
<13 13-19 20-29 30-39 40-49 50-59 60+
Transmission Category (Unadjusted)
Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown
Transmission Category (Adjusted)4
Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3
HIV diagnoses
N
%*
73
100.0
49
67.1
19
26.0
5
6.8
0
0.0
58
79.5
12
16.4
<5
--
0
0.0
0
0.0
0
0.0
0
0.0
5
6.8
32
43.8
21
28.8
7
9.6
7
9.6
<5
--
37
50.7
<5
--
0
0.0
18
24.7
0
0.0
0
0.0
17
23.3
47
63.8
<5
--
<5
--
22
30.0
0
0.0
0
0.0
PLWH as of 12/31/2020
N
%*
2,287
100.0
1,531
66.9
729
31.9
23
1.0
<5
--
1,725
75.4
380
16.6
76
3.3
<5
--
5
0.2
83
3.6
<5
--
46
2.0
283
12.4
435
19.0
360
15.7
632
27.6
527
23.0
898
39.3
144
6.3
90
3.9
496
21.7
74
3.2
<5
--
581
25.4
1,101
48.2
199
8.7
103
4.5
789
34.5
74
3.2
<5
--
* Percentages may not add up to 100% due to rounding 1. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 2. Includes perinatal exposure current age > 13; hemophilia, blood transfusion.3. Perinatal/other pediatric: cases <13 born to HIV-infected mother, and cases <13 with missing risk. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding
2020 Georgia HIV Surveillance Summary
Page 30
Table 21. HIV Diagnoses and Persons Living with HIV, District 7 (Columbus), Georgia, 2020
Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing
Total Gender Identity
Cisgender Male Cisgender Female Transgender Woman Transgender Man
Race/Ethnicity
Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races
Age Group (at diagnosis for diagnosed, current for PLWH)
<13 13-19 20-29 30-39 40-49 50-59 60+
Transmission Category (Unadjusted)
Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown
Transmission Category (Adjusted)4
Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3
HIV diagnoses
N
%*
87
100.0
58
66.7
28
32.2
<5
--
0
0.0
70
80.5
17
19.5
0
0.0
0
0.0
0
0.0
0
0.0
0
0.0
5
5.7
25
28.7
25
28.7
16
18.4
11
12.6
5
5.7
32
36.8
<5
--
0
0.0
30
34.5
0
0.0
0
0.0
22
25.3
43
49.2
5
5.2
<5
--
39
44.9
0
0.0
0
0.0
PLWH as of 12/31/2020
N
%*
1,918
100.0
1,264
65.9
636
33.2
12
0.6
0
0.0
1,417
73.9
244
12.7
110
5.7
<5
--
<5
--
83
4.3
<5
--
13
0.7
214
11.2
390
20.3
411
21.4
506
26.4
380
19.8
614
32.0
105
5.5
44
2.3
522
27.2
21
1.1
<5
--
608
31.7
850
44.3
147
7.7
60
3.1
773
40.3
21
1.1
<5
--
* Percentages may not add up to 100% due to rounding 1. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 2. Includes perinatal exposure current age > 13; hemophilia, blood transfusion.3. Perinatal/other pediatric: cases <13 born to HIV-infected mother, and cases <13 with missing risk. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding
2020 Georgia HIV Surveillance Summary
Page 31
Table 22. HIV Diagnoses and Persons Living with HIV, District 8-1 (Valdosta), Georgia, 2020
Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing
Total Gender Identity
Cisgender Male Cisgender Female Transgender Woman Transgender Man
Race/Ethnicity
Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races
Age Group (at diagnosis for diagnosed, current for PLWH)
<13 13-19 20-29 30-39 40-49 50-59 60+
Transmission Category (Unadjusted)
Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown
Transmission Category (Adjusted)4
Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3
HIV diagnoses
N
%*
47
100.0
40
85.1
7
14.9
0
0.0
0
0.0
37
78.7
8
17.0
<5
--
0
0.0
0
0.0
0
0.0
0
0.0
<5
--
20
42.6
4
8.5
10
21.3
7
14.9
<5
--
19
40.4
0
0.0
0
0.0
9
19.1
0
0.0
0
0.0
19
40.4
31
65.7
<5
--
0
0.2
15
32.6
0
0.0
0
0.0
PLWH as of 12/31/2020
N
%*
1,244
100.0
750
60.3
485
39.0
7
0.6
0
0.0
861
69.2
215
17.3
98
7.9
0
0.0
<5
--
57
4.6
<5
--
<5
--
131
10.5
229
18.4
266
21.4
357
28.7
256
20.6
356
28.6
53
4.3
32
2.6
464
37.3
7
0.6
<5
--
330
26.5
483
38.8
78
6.3
39
3.1
625
50.3
7
0.6
<5
--
* Percentages may not add up to 100% due to rounding 1. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 2. Includes perinatal exposure current age > 13; hemophilia, blood transfusion.3. Perinatal/other pediatric: cases <13 born to HIV-infected mother, and cases <13 with missing risk. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding
2020 Georgia HIV Surveillance Summary
Page 32
Table 23. HIV Diagnoses and Persons Living with HIV, District 8-2 (Albany), Georgia, 2020
Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing
Total Gender Identity
Cisgender Male Cisgender Female Transgender Woman Transgender Man
Race/Ethnicity
Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races
Age Group (at diagnosis for diagnosed, current for PLWH)
<13 13-19 20-29 30-39 40-49 50-59 60+
Transmission Category (Unadjusted)
Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown
Transmission Category (Adjusted)4
Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3
HIV diagnoses
N
%*
77
100.0
44
57.1
32
41.6
<5
--
0
0.0
64
83.1
12
15.6
<5
--
0
0.0
0
0.0
0
0.0
0
0.0
11
14.3
27
35.1
14
18.2
11
14.3
10
13.0
<5
--
30
39.0
<5
--
<5
--
23
29.9
0
0.0
0
0.0
21
27.3
36
47.1
5
6.1
<5
--
35
45.3
0
0.0
0
0.0
PLWH as of 12/31/2020
N
%*
1,792
100.0
1104
61.6
673
37.6
11
0.6
<5
--
1433
80.0
182
10.2
72
4.0
<5
--
<5
--
90
5.0
<5
--
18
1.0
225
12.6
362
20.2
372
20.8
449
25.1
362
20.2
610
34.0
73
4.1
42
2.3
432
24.1
23
1.3
<5
--
609
34.0
807
45.0
123
6.9
53
3.0
771
43.0
23
1.3
<5
--
* Percentages may not add up to 100% due to rounding 1. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 2. Includes perinatal exposure current age > 13; hemophilia, blood transfusion.3. Perinatal/other pediatric: cases <13 born to HIV-infected mother, and cases <13 with missing risk. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding
2020 Georgia HIV Surveillance Summary
Page 33
Table 24. HIV Diagnoses and Persons Living with HIV, District 9-1 (Savannah), Georgia, 2020
Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing
Total Gender Identity
Cisgender Male Cisgender Female Transgender Woman Transgender Man
Race/Ethnicity
Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races
Age Group (at diagnosis for diagnosed, current for PLWH)
<13 13-19 20-29 30-39 40-49 50-59 60+
Transmission Category (Unadjusted)
Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown
Transmission Category (Adjusted)4
Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3
HIV diagnoses
N
%*
101
100.0
76
75.2
23
22.8
<5
--
0
0.0
69
68.3
21
20.8
7
6.9
0
0.0
<5
--
0
0.0
0
0.0
6
5.9
35
34.7
28
27.7
10
9.9
16
15.8
6
5.9
42
41.6
<5
--
<5
--
16
15.8
0
0.0
0
0.0
39
38.6
60
58.9
6
6.1
<5
--
31
30.4
0
0.0
0
0.0
PLWH as of 12/31/2020
N
%*
2,823
100.0
1,894
67.1
896
31.7
22
0.8
<5
--
1,865
66.1
579
20.5
192
6.8
<5
--
11
0.4
139
4.9
8
0.3
16
0.6
318
11.3
615
21.8
483
17.1
772
27.3
610
21.6
1,057
37.4
153
5.4
65
2.3
551
19.5
34
1.2
7
0.2
956
33.9
1,427
50.6
229
8.1
90
3.2
998
35.4
34
1.2
7
0.2
* Percentages may not add up to 100% due to rounding 1. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 2. Includes perinatal exposure current age > 13; hemophilia, blood transfusion.3. Perinatal/other pediatric: cases <13 born to HIV-infected mother, and cases <13 with missing risk. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding
2020 Georgia HIV Surveillance Summary
Page 34
Table 25. HIV Diagnoses and Persons Living with HIV, District 9-2 (Waycross), Georgia, 2020
Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing
Total Gender Identity
Cisgender Male Cisgender Female Transgender Woman Transgender Man
HIV diagnoses
N
%*
47
100.0
38
80.9
8
17.0
<5
--
0
0.0
PLWH as of 12/31/2020
N
%*
1,266
100.0
834
65.9
424
33.5
7
0.6
0
0.0
Race/Ethnicity
Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races
26
55.3
772
61.0
13
27.7
267
21.1
7
14.9
115
9.1
0
0.0
0
0.0
0
0.0
<5
--
<5
--
84
6.6
Age Group (at diagnosis for diagnosed,
current for PLWH)
0
0.0
0
0.0
13-19
<5
--
<5
--
20-29
18
38.3
118
9.3
30-39
15
31.9
268
21.2
40-49
5
10.6
260
20.5
50-59
5
10.6
374
29.5
60+
<5
--
242
19.1
Transmission Category (Unadjusted)
Male-to-male sexual contact
18
38.3
410
32.4
Injection drug use
<5
--
65
5.1
Male-to-male sexual contact and injection drug use
<5
--
39
3.1
Heterosexual contact1
10
21.3
309
24.4
Adult Other2
0
0.0
12
0.9
Perinatal/other pediatric3
0
0.0
0
0.0
Unknown
16
34.0
431
34.0
Transmission Category (Adjusted)3
Male-to-male sexual contact
28
60.2
575
45.5
Injection drug use
<5
--
105
8.3
Male-to-male sexual contact and injection drug use
<5
--
50
3.9
Heterosexual contact1
15
30.9
498
39.4
Adult Other2
0
0.0
12
0.9
Perinatal/other pediatric3
0
0.0
0
0.0
* Percentages may not add up to 100% due to rounding 1. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 2. Includes perinatal exposure current age > 13; hemophilia, blood transfusion. 3. Perinatal/other pediatric: cases <13 born to HIV-infected mother, and cases <13 with missing risk. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding
2020 Georgia HIV Surveillance Summary
Page 35
Table 26. HIV Diagnoses and Persons Living with HIV, District 10 (Athens), Georgia, 2020
Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing
Total Gender Identity
Cisgender Male Cisgender Female Transgender Woman Transgender Man
Race/Ethnicity
Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races
Age Group (at diagnosis for diagnosed, current for PLWH)
<13 13-19 20-29 30-39 40-49 50-59 60+
Transmission Category (Unadjusted)
Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown
Transmission Category (Adjusted)4
Male-to-male sexual contact Injection drug use Male-to-male sexual contact and injection drug use Heterosexual contact1 Adult Other2 Perinatal/other pediatric3
HIV diagnoses
N
%*
42
100.0
30
71.4
10
23.8
<5
--
<5
--
23
54.8
10
23.8
5
11.9
0
0.0
<5
--
<5
--
0
0.0
<5
--
17
40.5
10
23.8
<5
9.5
6
14.3
<5
9.5
23
54.8
<5
--
0
0.0
10
23.8
0
0.0
0
0.0
7
16.7
25
59.0
<5
--
0
0.0
13
31.0
0
0.0
0
0.0
PLWH as of 12/31/2020
N
%*
1,101
100.0
742
67.4
339
30.8
17
1.5
<5
--
610
55.4
326
29.6
91
8.3
0
0.0
7
0.6
56
5.1
<5
---
8
0.7
126
11.4
258
23.4
227
20.6
262
23.8
217
19.7
448
40.7
62
5.6
34
3.1
225
20.4
13
1.2
<5
--
316
28.7
584
53.0
86
7.8
42
3.8
362
32.9
13
1.2
<5
--
* Percentages may not add up to 100% due to rounding 1. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 2. Includes perinatal exposure current age > 13; hemophilia, blood transfusion.3. Perinatal/other pediatric: cases<13 born to HIV-infected mother, and cases <13 with missing risk. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding
2020 Georgia HIV Surveillance Summary
Page 36
HIV Diagnoses and Persons Living with HIV, Atlanta MSA
Table 27. HIV Diagnoses and Persons Living with HIV, Atlanta Metropolitan Statistical Area1, Georgia, 2020
Total Gender Identity
Cisgender Male
HIV diagnoses
N 1,379
%* 100.0
1,094
79.3
PLWH as of 12/31/2020
N 42,257
%* 100.0
33,226
78.6
Cisgender Female
239
17.3
8,432
20.0
Transgender Woman
43
3.1
507
1.2
Transgender Man
<5
--
24
0.1
Race/Ethnicity
Black/Non Hispanic
1,008
73.1
29,182
69.0
White/Non Hispanic
183
13.3
6,945
16.4
Hispanic/Latino, Any Race
142
10.3
3,342
7.9
American Indian/Alaska Native
<5
20
0.0
Asian/Native Hawaiian/Pacific Islander
15
1.1
273
0.6
Multiple races
16
1.2
1,956
4.6
Age Group (at diagnosis for diagnosed,
current for PLWH)
<13
<5
--
50
0.1
13-19
62
4.5
175
0.4
20-29
576
41.8
4,740
11.2
30-39
392
28.4
10,439
24.7
40-49
173
12.5
9,089
21.5
50-59
128
9.3
10,958
25.9
60+
47
3.4
6,806
16.1
Transmission Category (Unadjusted)
Male-to-male sexual contact
855
62.0
24,011
56.8
Injection drug use
15
1.1
1,375
3.3
Male-to-male sexual contact and injection
19
1.4
1,336
3.2
drug use
Heterosexual contact2
213
15.4
6,127
14.5
Adult Other3
0
0.0
347
0.8
Perinatal/other pediatric4
0
0.0
44
0.1
Unknown
277
20.1
9,026
21.4
Transmission Category (Adjusted)5
Male-to-male sexual contact
988
71.7
28,396
67.2
Injection drug use
31
2.3
1,988
4.7
Male-to-male sexual contact and injection
24
1.7
1,631
3.9
drug use
Heterosexual contact2
322
23.3
9,307
22.0
Adult Other3
0
0.0
347
0.8
Perinatal/other pediatric4
0
0.0
44
0.1
*Percents may not add up to 100 due to rounding 1.Barrow, Bartow, Butts, Carroll, Cherokee, Clayton, Cobb, Coweta, Dawson, DeKalb, Douglas, Fayette, Forsyth, Fulton, Gwinnett, Haralson, Heard, Henry, Jasper, Lamar, Meriwether, Morgan, Newton, Paulding, Pickens, Pike, Rockdale, Spalding, Walton 2.Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure age>13, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases <13 years born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding
2020 Georgia HIV Surveillance Summary
Page 37
Late Diagnoses by Public Health District and Atlanta MSA
Table 28. Late diagnoses by Public Health District and for Atlanta Metropolitan Statistical Area, Georgia, 2020
Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing
HIV Diagnoses
Late HIV Diagnoses Stage 3 [AIDS] within 12 months
N
N
row %
District
1-1 Northwest (Rome) 1-2 North Georgia (Dalton) 2 North (Gainesville) 3-1 Cobb-Douglas 3-2 Fulton 3-3 Clayton (Jonesboro) 3-4 East Metro (Lawrenceville) 3-5 DeKalb 4 LaGrange 5-1 South Central (Dublin) 5-2 North Central (Macon) 6 East Central (Augusta) 7 West Central (Columbus) 8-1 South (Valdosta) 8-2 Southwest (Albany) 9-1 Coastal (Savannah) 9-2 Southeast (Waycross) 10 Northeast (Athens) Atlanta MSA1
53 23 48 160 481 113 185 278 96 16 83 73 87 47 77 101 47 42 1,379
17
32.1
5
21.7
12
25.0
42
26.3
92
19.1
21
18.6
43
23.2
60
21.6
16
16.7
4
25.0
19
22.9
18
24.7
26
29.9
14
29.8
22
28.6
28
27.7
10
21.3
10
23.8
298
21.6
1. Barrow, Bartow, Butts, Carroll, Cherokee, Clayton, Cobb, Coweta, Dawson, DeKalb, Douglas, Fayette, Forsyth, Fulton, Gwinnett, Haralson, Heard, Henry, Jasper, Lamar, Meriwether, Morgan, Newton, Paulding, Pickens, Pike, Rockdale, Spalding, Walton
2020 Georgia HIV Surveillance Summary
Page 38
Public Health District and County Rates
Table 29. HIV diagnoses and persons living with HIV (PLWH): Public Health District and County number and rates per 100,000 population, Georgia, 2020
Data for 2020 diagnoses should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing
HIV Diagnoses (all stages)
N1
1-1 Northwest (Rome)
53
Bartow County
8
Catoosa County
<5
Chattooga County
0
Dade County
<5
Floyd County
13
Gordon County
<5
Haralson County
<5
Paulding County
21
Polk County
<5
Walker County
<5
1-2 North Georgia (Dalton)
23
Cherokee County
12
Fannin County
<5
Gilmer County
<5
Murray County
<5
Pickens County
<5
Whitfield County
<5
2 North (Gainesville)
48
Banks County
0
Dawson County
<5
Forsyth County
14
Franklin County
<5
Habersham County
5
Hart County
16
Hall County
<5
Lumpkin County
0
Rabun County
0
Stephens County
<5
Towns County
<5
Union County
<5
White County
<5
3-1 Cobb/Douglas
160
Cobb County
137
Douglas County
23
3-2 Fulton
481
Fulton County
481
3-3 Clayton
113
Clayton County
113
3-4 East Metro
(Lawrenceville)
185
Gwinnett County
150
Newton County
22
2020 Georgia HIV Surveillance Summary
Rate/100,0002,3
7.7 7.3 -0.0 -13.2 --12.1 --4.6 4.5 -----6.4 0.0 -5.6 -10.9 7.7 -0.0 0.0 ----17.6 18.0 15.5 44.6 44.6 38.6 38.6
16.1 15.9 19.4
PLWH as of 12/31/2020
N1
1,239 233 72 53 15 245 74 35 370 66 76 722 403 36 60 36 40 147 963 13 31 228 45 75 350 48 37 20 49
9 33 25 4,311 3,619 692 16,377 16,377 3,056 3,056
4,532 3,672 417
Rate/100,0002,3
178.9 212.9 105.9 213.3 93.4 248.5 125.9 115.2 213.4 154.1 108.4 144.2 151.9 135.7 187.6 89.9 120.7 141.6 129.1 67.2 114.3 90.9 191.5 162.9 169.4 181.8 108.2 115.8 187.7 73.5 130.1 80.4 473.3 474.3 467.6 1520.0 1520.0 1044.3 1044.3
395.2 389.5 368.1
Page 39
Rockdale County
3-5 DeKalb
13
14.3
278
36.5
DeKalb County
4 LaGrange
278
36.5
96
10.8
Butts County
10
39.3
Carroll County
8
6.6
Coweta County
13
8.6
Fayette County
8
6.9
Heard County
0
0.0
Henry County
39
16.3
Lamar County
<5
--
Meriwether County
<5
--
Pike County
0
0.0
Spalding County
6
8.9
Troup County
7
10.0
Upson County
<5
3.8
5-1 South Central (Dublin)
16
10.7
Bleckley County
<5
--
Dodge County
<5
--
Johnson County
<5
--
Laurens County
8
16.8
Montgomery County
0
0.0
Pulaski County
0
0.0
Telfair County
0
0.0
Treutlen County
<5
--
Wheeler County
0
0.0
Wilcox County
<5
--
5-2 North Central (Macon)
83
15.4
Baldwin County
<5
--
Bibb County
42
27.5
Crawford County
<5
--
Hancock County
<5
--
Houston County
21
13.1
Jasper County
<5
--
Jones County
<5
--
Monroe County
<5
--
Peach County
5
17.9
Putnam County
<5
--
Twiggs County
0
0.0
Washington County
<5
--
Wilkinson County
0
0.0
6 East Central (Augusta)
73
14.8
Burke County
5
22.1
Columbia County
8
5.0
Emanuel County
0
0.0
Glascock County
0
0.0
Jefferson County
5
32.8
Jenkins County
0
0.0
Lincoln County
<5
--
McDuffie County
<5
--
Richmond County
50
24.7
Screven County
<5
--
Taliaferro County
0
0.0
Warren County
<5
--
Wilkes County
0
0.0
7 West Central (Columbus)
87
23.6
Chattahoochee County
0
0.0
2020 Georgia HIV Surveillance Summary
443 9,974 9,974 2,529 116 254 285 229
14 1,005
47 75 13 227 196 68 608 48 80 32 197 15 25 88 23 31 69 2,332 164 1,249 23 45 456 23 48 57 127 36 23 60 21 2,287 101 236 61 7 57 34 18 63 1,611 46 9 20 24 1,918 13
487.1 1308.9 1308.9 284.6 456.2 208.8 188.9 197.7 116.9 420.3 244.0 354.4
68.0 336.7 279.1 256.3 406.3 370.5 391.2 331.0 414.6 166.4 223.4 557.6 337.1 399.9 811.6 433.8 363.6 817.7 188.0 529.8 284.8 158.8 166.7 203.3 454.4 159.9 283.8 297.8 238.3 462.7 446.0 147.2 271.0 234.6 373.4 388.7 224.1 297.7 797.2 328.3 576.2 382.3 247.6 519.4 123.2
Page 40
Clay County
0
0.0
Crisp County
7
31.8
Dooly County
<5
--
Harris County
<5
--
Macon County
<5
--
Marion County
0
0.0
Muscogee County
68
34.6
Quitman County
0
0.0
Randolph County
<5
--
Schley County
0
0.0
Stewart County4
0
0.0
Sumter County
<5
--
Talbot County
0
0.0
Taylor County
0
0.0
Webster County
8-1 South (Valdosta)
0
0.0
47
18.1
Ben Hill County
<5
--
Berrien County
0
0.0
Brooks County
<5
--
Cook County
5
28.9
Echols County
<5
--
Irwin County
<5
--
Lanier County
<5
--
Lowndes County
27
22.8
Tift County
8
19.6
Turner County
<5
--
8-2 Southwest (Albany)
77
22.6
Baker County
0
0.0
Calhoun County
0
0.0
Colquitt County
11
24.2
Decatur County
6
22.7
Dougherty County
38
43.9
Early County
0
0.0
Grady County
<5
--
Lee County
<5
--
Miller County
0
0.0
Mitchell County
5
23.1
Seminole County
<5
--
Terrell County
0
0.0
Thomas County
7
15.8
Worth County
<5
--
9-1 Coastal (Savannah)
101
15.9
Bryan County
<5
--
Camden County
0
0.0
Chatham County
63
21.8
Effingham County
6
9.1
Glynn County
18
21.0
Liberty County
12
19.0
Long County
0
0.0
McIntosh County
0
0.0
9-2 Southeast (Waycross)
47
12.5
Appling County
<5
--
Atkinson County
<5
--
Bacon County
<5
--
Brantley County
0
0.0
Bulloch County
14
17.3
Candler County
0
0.0
2020 Georgia HIV Surveillance Summary
13 141 65 44 72 14 1,176
5 42 6 123 142 27 32 3 1,244 58 39 63 76 15 86 25 663 171 48 1,792 7 34 210 136 791 26 69 73 20 108 25 44 172 77 2,823 56 99 1,880 93 358 255 24 58 1,266 39 21 43 21 278 34
453.6 639.9 493.4 122.0 566.4 164.4 598.6 220.2 628.6 115.5 1838.8 484.9 439.5 396.3 115.6 479.1 349.1 200.9 410.2 439.5 374.8 916.2 232.8 560.6 420.0 609.0 526.1 235.6 545.7 461.1 514.0 914.7 259.0 281.7 241.5 355.7 500.0 310.2 516.3 387.6 385.5 444.9 137.4 178.7 649.5 141.4 418.4 404.7 119.0 403.1 337.1 212.8 250.2 389.6 109.4 343.9 309.5
Page 41
Charlton County
<5
--
Clinch County
0
0.0
Coffee County
6
13.9
Evans County
<5
--
Jeff Davis County
0
0.0
Pierce County
<5
--
Tattnall County
<5
--
Toombs County
<5
--
Ware County
6
16.7
Wayne County
<5
--
10 Northeast (Athens)
42
7.9
Barrow County
6
7.0
Clarke County
23
18.0
Elbert County
<5
--
Greene County
<5
--
Jackson County
0
0.0
Madison County
<5
--
Morgan County
<5
--
Oconee County
<5
--
Oglethorpe County
<5
--
Walton County
<5
--
74 27 124 47 31 30 102 97 183 115 1,101 141 459 40 30 88 37 36 29 30 211
551.0 410.2 286.9 441.8 203.8 153.7 402.1 359.6 510.8 383.0 207.3 164.7 359.2 206.9 159.3 115.5 121.5 183.3 70.5 195.0 217.8
1. Values of 1-4 are censored 2. Rates are not calculated when numerator is <12. 3. Persons residing in correctional facilities are included in this report and may inflate rates in certain geographic regions where there are large numbers of HIV-positive inmates. 4. Most cases associated with a federal immigration detention facility located in this county.
2020 Georgia HIV Surveillance Summary
Page 42
Distribution of General Population by Race/Ethnicity
Table 30. Distribution of the general population by race/ethnicity, Georgia 2020
Race/Ethnicity
White, Non-Hispanic Black, Non-Hispanic Hispanic/Latino, Any Race Asian, Non-Hispanic American Indian /Alaskan Native, Non-Hispanic Native Hawaiian/Pacific Islander, Non-Hispanic Total
Number (%) 5,522,339
3,406,103
1,067,941
471,825 24,535
7,564 10,710,017
Source: Georgia Online Analytical Statistical Information System (https://oasis.state.ga.us/oasis/webquery/qryPopulation.aspx)
2020 Georgia HIV Surveillance Summary
Page 43
HIV/AIDS RESOURCES:
Georgia Department of Public Health http://dph.georgia.gov/what-hiv-and-aids
Centers for Disease Control and Prevention http://www.cdc.gov/hiv/
AIDSVu http://aidsvu.org/
Reporting All health care providers diagnosing and/or providing care to a patient with HIV are required by Georgia law (O.C.G.A. 31-12-1) to report HIV infection using the HIV/AIDS Case Report Form. Case report forms should be completed within seven (7) days of diagnosing a patient with HIV and/or AIDS or within seven (7) days of assuming care of an HIV positive patient who is new to the provider, regardless of whether the patient has previously received care elsewhere. Adult and Pediatric case report forms are available at https://dph.georgia.gov/hivaids-case-reporting For more questions on HIV case reporting in Georgia please contact the HIV Surveillance Coordinator at 1800-827-9769
2020 Georgia HIV Surveillance Summary
Page 44